|
HS Code |
447711 |
As an accredited 5-Bromo-1-Methylbenzimidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-1-Methylbenzimidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists and researchers have long looked for molecules that can deliver both selectivity and reliability in synthetic work. 5-Bromo-1-Methylbenzimidazole grabs attention for its versatility and the subtle power in its structure. Known as a high-purity reagent with the chemical formula C8H7BrN2, this compound brings confidence to projects centered around heterocyclic chemistry, building blocks for pharmaceuticals, and next-generation material science. It is recognizable by its crystalline, off-white to pale beige appearance, and its presence often signals a designer’s intent to push for tighter synthetic control or improved downstream properties.
Years spent at the lab bench have taught me to spot the difference between a stock chemical that just gets the job done and one that helps solve complex problems. The methyl group at the first position of the benzimidazole ring and the bromine at the fifth position together open doors that are hard to match with more ordinary benzimidazole derivatives. Anyone familiar with the hunt for reliable starting materials knows how valuable a reagent with selective reactivity can be—it can reduce purification headaches and minimize byproduct formation. It is not unusual to see colleagues reach for this compound when working up new kinase inhibitors or optimizing ligands for metal-catalyzed coupling reactions.
In chemical development, the smallest tweak on a ring structure often means the difference between a successful reaction and a dead end. Take 5-bromo-1-methylbenzimidazole and put it next to 1-methylbenzimidazole. Adding a bromine atom at the fifth position creates an entry point for cross-coupling reactions such as Suzuki, Stille, and Heck. This difference grants it broader application compared to its unbrominated cousin, which lacks a useful handle for halogen-metal exchange or palladium-catalyzed activation. In my own projects, the bromo version integrated into structure-activity relationship studies, while the non-brominated type felt limited to analoging work without much flexibility.
Researchers in drug discovery find value in molecules with modular reactivity. By introducing a bromine atom, this compound opens multiple synthetic pathways, allowing for rapid exploration of analog libraries. Medicinal chemists, for instance, appreciate that the benzimidazole core brings bioactivity potential, while the bromine can be swapped out for more complex units using common cross-coupling techniques. I have seen research groups move seamlessly from the bromo starting material to thioethers, amides, and aryl derivatives in just a few steps. This streamlines target synthesis, cuts down on labor, and keeps focus on exploring new biological space.
What sets this material apart, besides its molecular structure, usually comes down to its purity and form. Labs and production teams seek a reliable supply—high purity, consistent appearance, minimal byproducts. In my experience, good product flows from producers who understand the expectations of pharmaceutical and academic labs alike. Fine powders or crystalline material with high assay values (typically over 98%) save hours in post-reaction clean-ups, and good solubility in common reaction solvents—like DMF, DMSO, and acetonitrile—helps reactions proceed smoothly. Moisture and air stability have always added a layer of comfort, especially during scale-up or storage outside controlled-atmosphere boxes.
Synthetic chemists often gravitate toward reagents that cut down on steps or enable new bonds without complicated protection-deprotection cycles. One reason many labs embrace 5-bromo-1-methylbenzimidazole is how smoothly it integrates into alkylation, arylation, and heterocycle-extension protocols. Once, at a university combinatorial chemistry lab, I watched a new graduate student push out dozens of new analogs inside a single week by pivoting from routine couplings to using this bromo compound as an anchor. The shift didn’t require fancy equipment or proprietary reagents—just a smart choice at the starting line.
Seasoned chemists usually go beyond what's printed on a product data sheet. Reliability depends on how a compound behaves batch after batch. I’ve run TLCs and NMRs on material straight from the bottle, and the best batches always match spectra cleanly, without detectable impurities or shifting peaks. Minor impurities in this compound can significantly disrupt downstream processes, especially if moving toward regulated drug work. That’s why working with consistent, traceable suppliers is not just wise—it’s a necessity. I’ve seen time and grant money wasted with poor supplies, so clean material with traceable certifications always wins out.
A closer look at similar products highlights what makes 5-bromo-1-methylbenzimidazole practical. Compared to non-methylated or non-brominated benzimidazole derivatives, you gain both electronic and steric tuning. The bromine atom not only invites further functionality, it can change the compound’s electron density—a key factor impacting reactivity rates and the types of partners that handle it best. During a recent lead optimization project, the difference between the methylated and non-methylated versions became decisive, with the extra methyl delivering better metabolic stability in the screening assay. Distinctions like this are not always obvious from catalog tables but they emerge crystal-clear after several rounds of trial in both chemical and biological settings.
Researchers add 5-bromo-1-methylbenzimidazole to toolkits focused on building advanced molecules. Take its use in preparing complex ligands for transition metal catalysis. Bromo-substituted heterocycles turn into precious intermediates for embedding new functionality into pharmaceutical candidates and novel materials. In my work designing light-absorbing dyes for organic solar cells, this compound’s reactivity at the bromo position enabled rapid diversification, which brought improvements in panel efficiency. The same kinds of cross-coupling tools translate to device and polymer labs, where teams chase unique emission or conductance profiles by installing new groups onto a benzimidazole backbone.
Chemists build lasting solutions on the design of the right chemical frameworks. The addition of a methyl group at N1 and a bromine at C5 gives this molecule a distinct feel; it is not just about what reactions it can do but how it does them. The electron-donating nature of methyl pushes reactivity in subtle directions, favoring certain bond-forming reactions over others. Bromine, being a good leaving group, makes it possible to build out larger structures using standard synthetic methods. Colleagues working with DNA mimetics or novel enzyme inhibitors often comment on the ease with which this compound slots into several modular reaction schemes.
Demand drives availability, and this compound now finds a home on most established chemical supplier shelves. Reliable sources prioritize consistent purity and well-controlled packing to avoid cross-contamination with related benzene derivatives. Having a trustworthy source becomes even more important in regulated industries, where every raw material moves through documentation trails that must stand up to legal or regulatory scrutiny. In start-up environments where chemistry must move fast, the chance to pick up high-quality material in reasonable pack sizes—from gram quantities for discovery work up to kilograms for early process optimization—makes a significant difference in project momentum.
Starting in the academic setting, graduate students and postdocs pick up 5-bromo-1-methylbenzimidazole for focused structure-activity efforts. Once a hit or lead emerges, scale-up teams want to keep using the same reagent. My own push from bench discovery to pilot-scale synthesis taught me to value good handling properties—low hygroscopicity, stable shelf life, and a manageable melting point prove themselves every step along the way. Engineering teams often mention reduced risk of decomposition and manageable dust hazards compared to others in the same chemical class. Reduced handling issues mean less downtime and fewer reworks, easing scale-up headaches before they start.
Awareness of chemical safety and environmental impact has rightly moved to the front line of modern labs. While 5-bromo-1-methylbenzimidazole fits the design needs for effective synthetic schemes, safe handling and good housekeeping keep risk low. Proper ventilation, avoidance of skin contact, and diligent storage figure into every protocol. I’ve seen waste streams closely managed to avoid halogenated byproducts escaping into municipal systems; following solid waste separation and licensed incineration remains good practice. Emerging greener protocols sometimes use this molecule in catalytic reactions with reduced waste and milder conditions, which matches the drive for sustainability in research and production settings today.
Pharmaceutical and biotech users operate in tightly regulated frameworks where documentation and traceability of all ingredients are not optional. Batch certifications, adherence to country-specific chemical inventory lists, and transparent records on impurities matter. As more teams look toward clinical trials or product registration, secure documentation for every lot of material allows seamless audits and removes the uncertainty from regulatory submissions. I’ve seen talented teams stumble because supply could not match demanding paperwork; a robust audit trail from supplier to shelf can save months in the long run.
Best lab practices favor storing 5-bromo-1-methylbenzimidazole in tightly sealed containers at controlled room temperature, shielded from direct light and excessive humidity. Clean tools, careful weighing, and swift transfer into reaction vessels help preserve both potency and purity. I have lost samples in shared labs to careless storage near bases or oxidizers, which underlines the importance of good habits in shared workspaces. Building a clear inventory system has helped keep research flowing smoothly without too many surprises from degraded or contaminated stock.
Every research group has those moments where a carefully selected reagent brings a project back from the brink. 5-bromo-1-methylbenzimidazole has been part of those stories more than once, especially for teams struggling with sluggish or messy couplings. In my experience, choosing the right substitution pattern on a benzimidazole ring sets up a win for late-stage diversification or hit-expansion projects. The difference in user experience compared to less functionalized or less pure analogs really comes through not just in yield, but in the speed and clarity of purification. The less time spent on column work or prep HPLC, the more productive the lab becomes.
Scientific progress depends on smart, reliable molecules that expand the range of what’s possible. 5-bromo-1-methylbenzimidazole fits this need by merging robust core chemistry with handles for deeper exploration. Its role as a starting point for new heterocycles sets up hundreds of possible downstream molecules for testing as drugs, materials, or catalysts. I have watched innovation accelerate in labs where the right building blocks come quickly, with proven consistency; talented teams need to focus less on troubleshooting raw materials and more on solving grander scientific questions.
Market trends show an uptick in both academic and industrial demand for versatile bromo-heterocycles. More start-ups in AI-driven drug discovery or organic electronics seem to tap into molecules like this as key search-space expanders. Ease of modification, strong support for fast SAR, and commercial supply chains keep this compound central in many current discovery platforms. Feedback from process chemists matches these experiences, with recurring reports of low impurity profiles and manageable process risk compared to less sophisticated reagents.
The landscape of synthetic chemistry keeps evolving, with new tools, catalysts, and green protocols showing up each year. Building blocks like 5-bromo-1-methylbenzimidazole don’t disappear as new technologies arise—they become more valuable, supporting next-generation reactions that demand selectivity, stability, and creative extension. Open collaboration spaces and cross-disciplinary teams now use these types of molecules to build everything from protein-ligand interaction probes to components for flexible electronics and imaging agents. This compound’s track record supports its continued use in both routine and innovative settings.
Feedback from across industries nudges suppliers toward even higher purity, reduced trace metals, and larger range of packaging sizes. In my own teams, direct links between chemists and suppliers, plus clear batch histories, let us flag minor issues before they become big ones. Expansion of technical support, access to analytical data beyond the standard COA, or open communication channels with QA teams have already improved turnaround and confidence for users with strict specifications. These incremental improvements all tie back to smoother research progress and more reliable outcomes at the bench.
With the shift toward personalized medicine, green chemical processes, and smart materials, demand for reliable, multifunctional molecules like 5-bromo-1-methylbenzimidazole will only grow. At each stage in the synthesis pipeline, chemists need partners that bring both innovation and dependability. I see this compound moving further into screening cascades, probe design, and adaptive material synthesis. The core lesson remains that progress builds on dependable foundations, and this particular benzimidazole variant continues to show its worth, year after year, molecule after molecule.